The Social Cure: A revelatory examination of the future of HIV/AIDS and how current networking technology empowers us to affect change.

Infographics: Using The Olympic Rings To Show Vast Inequalities

People living with HIV. Oceania: blue. Europe: black. Americas: red. Asia: green. Africa: yellow.

kthread:

doctorswithoutborders:

Johnson & Johnson is expected to announce Monday, December 19, whether it intends to license its patents on three lifesaving HIV/AIDS drugs to the Medicines Patent Pool, a mechanism designed to lower prices of HIV medicines and increase access to them for people in the developing world.
Over the past two years, Doctors Without Borders/Médecins Sans Frontières (MSF) has been urging Johnson & Johnson to take this critical step.
Johnson & Johnson has so far refused to join discussions on licensing these patents to the Medicines Patent Pool. The Pool has been set up to increase access to more affordable versions of HIV drugs, including fixed-dose combinations that include multiple medicines in one pill, and to develop much-needed pediatric HIV drugs.
The Pool would license patents on HIV drugs to other manufacturers and the resulting competition would dramatically reduce prices, making them much more affordable in the developing world. However, since the Pool is voluntary it will only work if patent holders like Johnson & Johnson choose to participate.
ACT NOW: Call on Johnson & Johnson to finally join the Medicines Patent Pool

This is a big deal. 

kthread:

doctorswithoutborders:

Johnson & Johnson is expected to announce Monday, December 19, whether it intends to license its patents on three lifesaving HIV/AIDS drugs to the Medicines Patent Pool, a mechanism designed to lower prices of HIV medicines and increase access to them for people in the developing world.

Over the past two years, Doctors Without Borders/Médecins Sans Frontières (MSF) has been urging Johnson & Johnson to take this critical step.

Johnson & Johnson has so far refused to join discussions on licensing these patents to the Medicines Patent Pool. The Pool has been set up to increase access to more affordable versions of HIV drugs, including fixed-dose combinations that include multiple medicines in one pill, and to develop much-needed pediatric HIV drugs.

The Pool would license patents on HIV drugs to other manufacturers and the resulting competition would dramatically reduce prices, making them much more affordable in the developing world. However, since the Pool is voluntary it will only work if patent holders like Johnson & Johnson choose to participate.

ACT NOW: Call on Johnson & Johnson to finally join the Medicines Patent Pool

This is a big deal. 

CrowdOutAIDS is a collaborative online project to develop a new way for UNAIDS to work with young people.

It uses online tools to help young people come together to crowdsource a UNAIDS youth strategy on HIV.

CrowdOutAIDS will:

  • Connect young people who want to help out through tools like Facebook, blogs, Orkut and Google docs.
  • Engage in conversations about the key issues young people face.
  • Put decision-making in the hands of young people.
  • Collectively agree on actions—and get young people to draft the strategy!

Today on GOOD: United Nations Crowdsources the Future of Youth AIDS Prevention

The Man Who Had HIV and Now Does Not

Four years ago, Timothy Brown underwent an innovative procedure. Since then, test after test has found absolutely no trace of the virus in his body. The bigger miracle, though, is how his case has experts again believing they just might find a cure for AIDS.

HIV virus made of glass by Luke Jerram. (via

Project Masiluleke is a breakthrough initiative to combat HIV/AIDS using mobile technology in South Africa.

The project is designed for scale and is reaching millions of people.

We’re proud to announce that Project Masiluleke has just been awarded Gold at the South African Impumelelo Awards!